ArticleJHEP reports : innovation in hepatology2022

CRISPR-targeted genome editing of human induced pluripotent stem cell-derived hepatocytes for the treatment of Wilson's disease.

Rui Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.